Jiménez Galán, R.; Prado-Mel, E.; Pérez-Moreno, M.A.; Caballano-Infantes, E.; Flores Moreno, S.
Influence of Performance Status on the Effectiveness of Pembrolizumab Monotherapy in First-Line for Advanced Non-Small-Cell Lung Cancer: Results in a Real-World Population. Biology 2021, 10, 890.
https://doi.org/10.3390/biology10090890
AMA Style
Jiménez Galán R, Prado-Mel E, Pérez-Moreno MA, Caballano-Infantes E, Flores Moreno S.
Influence of Performance Status on the Effectiveness of Pembrolizumab Monotherapy in First-Line for Advanced Non-Small-Cell Lung Cancer: Results in a Real-World Population. Biology. 2021; 10(9):890.
https://doi.org/10.3390/biology10090890
Chicago/Turabian Style
Jiménez Galán, RocÃo, Elena Prado-Mel, MarÃa Antonia Pérez-Moreno, EstefanÃa Caballano-Infantes, and Sandra Flores Moreno.
2021. "Influence of Performance Status on the Effectiveness of Pembrolizumab Monotherapy in First-Line for Advanced Non-Small-Cell Lung Cancer: Results in a Real-World Population" Biology 10, no. 9: 890.
https://doi.org/10.3390/biology10090890
APA Style
Jiménez Galán, R., Prado-Mel, E., Pérez-Moreno, M. A., Caballano-Infantes, E., & Flores Moreno, S.
(2021). Influence of Performance Status on the Effectiveness of Pembrolizumab Monotherapy in First-Line for Advanced Non-Small-Cell Lung Cancer: Results in a Real-World Population. Biology, 10(9), 890.
https://doi.org/10.3390/biology10090890
